HomeBOT • ASX
add
Botanix Pharmaceuticals Ltd
Previous close
$0.11
Day range
$0.11 - $0.13
Year range
$0.11 - $0.54
Market cap
245.17M AUD
Avg Volume
7.83M
P/E ratio
-
Dividend yield
-
Primary exchange
ASX
Market news
Financials
Income Statement
Revenue
Net income
| (AUD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 2.71M | 219.92% |
Operating expense | 26.90M | 618.83% |
Net income | -27.75M | -560.61% |
Net profit margin | -1.03K | -106.50% |
Earnings per share | — | — |
EBITDA | -24.90M | -492.72% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (AUD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 64.97M | -18.08% |
Total assets | 129.10M | 14.79% |
Total liabilities | 47.80M | 1,180.69% |
Total equity | 81.30M | — |
Shares outstanding | 1.96B | — |
Price to book | 2.75 | — |
Return on assets | -49.33% | — |
Return on capital | -77.17% | — |
Cash Flow
Net change in cash
| (AUD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -27.75M | -560.61% |
Cash from operations | -24.01M | -999.67% |
Cash from investing | -97.95K | 93.92% |
Cash from financing | 32.48M | -4.95% |
Net change in cash | 8.26M | -72.90% |
Free cash flow | -9.59M | -245.54% |
About
Botanix Pharmaceuticals is listed on the Australian Securities Exchange with the issue code BOT. The Company is headquartered in Perth, Western Australia and Philadelphia, USA. It is a clinical stage synthetic cannabinoid company, focusing on the compound Cannabidiol. The company has two separate development platforms, dermatology and antimicrobial. Botanix also has an exclusive license to use a proprietary drug delivery system Permetrex, for direct skin delivery of active pharmaceuticals which is utilised in all of their programs. Wikipedia
Founded
1984
Website
Employees
11
